Cat NO. |
Product Name |
CM1170605 |
|
CM1185931 |
|
CM866526 |
CEP290 (NPHP6, CEP290, Centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) |
CM830640 |
CEP290 (NPHP6, CEP290, centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) |
CM1073384 |
CEP290 (NPHP6, CEP290, centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) (AP) |
CM1073385 |
CEP290 (NPHP6, CEP290, Centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) (AP) |
CM1076485 |
CEP290 (NPHP6, CEP290, Centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) (APC) |
CM1076484 |
CEP290 (NPHP6, CEP290, centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) (APC) |
CM1079584 |
CEP290 (NPHP6, CEP290, centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) (Biotin) |
CM1079585 |
CEP290 (NPHP6, CEP290, Centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) (Biotin) |
CM866525 |
CEP290 (NPHP6, CEP290, centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) (Control Peptide) |
CM1082684 |
CEP290 (NPHP6, CEP290, centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) (FITC) |
CM1082685 |
CEP290 (NPHP6, CEP290, Centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) (FITC) |
CM1085785 |
CEP290 (NPHP6, CEP290, Centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) (HRP) |
CM1085784 |
CEP290 (NPHP6, CEP290, centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) (HRP) |
CM1088884 |
CEP290 (NPHP6, CEP290, centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) (PE) |
CM1088885 |
CEP290 (NPHP6, CEP290, Centrosomal protein 290kD, 3H11Ag, FLJ13615, FLJ21979, JBTS5, JBTS6, KIAA0373, LCA10, MKS4, NPHP6, SLSN6, rd16, CTCL tumor antigen se2-2, nephrocystin 6, prostate cancer antigen T2) (PE) |
CM866523 |
|
CM1238106 |
|
CM1249084 |
|
CM1174953 |
|
CM1260062 |
|
CM1163362 |
|
CM1185932 |
|
CM1296927 |
|
CM1243881 |
|
CM1254859 |
|
CM1174954 |
|
CM1265838 |
|
CM1169137 |
|
CM1185933 |
|
CM925964 |
|
CM925813 |
|
CM927112 |
|
CM970139 |
|
CM925345 |
|
CM1292416 |
|
CM1239480 |
|
CM1250458 |
|
CM1174958 |
|
CM1261436 |
|
CM1164736 |
|
CM1185937 |
|
CM928217 |
|
CM1290994 |
|
CM803643 |
|
CM548016 |
|
CM586683 |
|
CM961857 |
|
CM695550 |
|
CM1231643 |
|
CM823575 |
|
CM823663 |
|
CM839694 |
|
CM1092526 |
|
CM1198861 |
|
CM866533 |
|
CM893505 |
|
CM958812 |
|
CM616039 |
|
CM642680 |
|
CM958351 |
|
CM616078 |
|
CM666991 |
|
CM627385 |
|
CM627382 |
|
CM853836 |
|
CM964621 |
|
CM596505 |
|
CM1094227 |
|
CM230048 |
|
CM230049 |
|
CM516219 |
|
CM516220 |
|
CM604512 |
|
CM950373 |
|
CM694870 |
|
CM694124 |
|
CM694407 |
|
CM251241 |
|
CM961019 |
|
CM919307 |
|
CM961945 |
|
CM685705 |
|
CM682252 |
|
CM685472 |
|
CM686190 |
|
CM682251 |
|
CM863624 |
c-erbB2 (CD340, ERBB2, HER2, HER-2, HER-2/neu, Metastatic Lymph Node Gene 19 Protein, MLN 19, MLN19, NEU, NGL, p185erbB2, Proto-oncogene c-ErbB-2, Proto-oncogene Neu, Receptor Tyrosine Protein Kinase erbB-2, TKR1, Tyrosine Kinase-type Cell Surface Recepto |
CM685277 |
|
CM613440 |
|
CM613651 |
|
CM586701 |
|
CM863626 |
c-erbB3, CT (HER 3, ErbB3, ErbB-3, erbB3-S, HER3, LCCS2, MDA-BF-1, MGC88033, p45 sErbB3, p85 sErbB3, p180 ErbB3) |
CM833256 |
|
CM841490 |
|
CM838266 |
c-erbB-2 (ERBB2, v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian), CD340, CD340 antigen, C-erbB-2, c-erb B2, HER2, HER-2, HER-2/neu, MLN 19, NEU, NEU proto-oncogene, NGL, p185erbB2, Receptor ty |
CM535527 |
|
CM535529 |
|
CM682161 |
|